Bridging the gap between bench and bedside: Systematic review of treatment in experimental acute pancreatitis

Modes of action included microcirculatory modification [Trials (T) 38, Compounds (C) 19; RCTs 4, Multiple compounds in individual RCTs (CRCT) 2], anti-inflammatory agents (T 31, C 21, RCTs 0), eicosanoid modulators (T 32, C 16; RCTs 3, CRCT 1), immune-modulators (T 35, C 23; RCTs 13, CRCT 5), protea...

Full description

Saved in:
Bibliographic Details
Published in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2013-03, Vol.13 (2), p.e37-e37
Main Authors: Javed, M.A, Altaf, K, Huang, W, Criddle, D.N, Sutton, R
Format: Article
Language:English
Subjects:
Endocrinology & Metabolism
Gastroenterology and Hepatology
Medical research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Modes of action included microcirculatory modification [Trials (T) 38, Compounds (C) 19; RCTs 4, Multiple compounds in individual RCTs (CRCT) 2], anti-inflammatory agents (T 31, C 21, RCTs 0), eicosanoid modulators (T 32, C 16; RCTs 3, CRCT 1), immune-modulators (T 35, C 23; RCTs 13, CRCT 5), protease inhibitors (T 31, C 12; RCTs 34, CRCT 5), secretion inhibitors (T 28, C 13; RCTs 40, CRCT 2), antioxidants (T 18, C 8; RCTs 14, CRCT 4) and multiple actions (T 24, C 16; RCTs 6, CRCT 2).
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2012.12.183